MARRONE BIO INNOVATIONS INC. Operating Lease Cost
MARRONE BIO INNOVATIONS INC. reported Operating Lease Cost of $381.00 thousand for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-13.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseCost · last filed 2022-05-13
- MARRONE BIO INNOVATIONS INC. operating lease, cost for the quarter ending 2022-03-31 was $381.00K, a 31.38% increase year-over-year.
- MARRONE BIO INNOVATIONS INC. operating lease, cost for the quarter ending 2021-12-31 was $421.00K, a 47.72% increase year-over-year.
- MARRONE BIO INNOVATIONS INC. operating lease, cost for the quarter ending 2021-09-30 was $327.00K, a 12.76% increase year-over-year.
- MARRONE BIO INNOVATIONS INC. operating lease, cost for the quarter ending 2021-06-30 was $326.00K, a 12.80% increase year-over-year.
- MARRONE BIO INNOVATIONS INC. operating lease, cost for fiscal 2021 was $1.36M, a 18.71% increase from fiscal 2020.
- MARRONE BIO INNOVATIONS INC. operating lease, cost for fiscal 2020 was $1.15M, a 0.43% decline from fiscal 2019.
- MARRONE BIO INNOVATIONS INC. operating lease, cost for fiscal 2019 was $1.15M.
| Period end | Operating Lease, Cost 3 month | Operating Lease, Cost 6 month | Operating Lease, Cost 9 month | Operating Lease, Cost 12 month |
|---|---|---|---|---|
| 2022-03-31 | $381.00K 10-Q · filed 2022-05-13 | $802.00K derived: sum of 2 quarters · filed 2022-05-13 | $1.13M derived: sum of 3 quarters · filed 2022-05-13 | $1.46M derived: sum of 4 quarters · filed 2022-05-13 |
| 2021-12-31 | $421.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-05-09 | $748.00K derived: sum of 2 quarters · filed 2022-05-09 | $1.07M derived: sum of 3 quarters · filed 2022-05-09 | $1.36M 10-K/A · filed 2022-05-09 |
| 2021-09-30 | $327.00K 10-Q · filed 2021-11-10 | $653.00K derived: sum of 2 quarters · filed 2021-11-10 | $943.00K 10-Q · filed 2021-11-10 | $1.23M derived: sum of 4 quarters · filed 2022-05-13 |
| 2021-06-30 | $326.00K 10-Q · filed 2021-08-16 | $616.00K 10-Q · filed 2021-08-16 | $901.00K derived: sum of 3 quarters · filed 2022-05-13 | $1.19M derived: sum of 4 quarters · filed 2022-05-13 |
| 2021-03-31 | $290.00K 10-Q · filed 2022-05-13 | $575.00K derived: sum of 2 quarters · filed 2022-05-13 | $865.00K derived: sum of 3 quarters · filed 2022-05-13 | $1.15M derived: sum of 4 quarters · filed 2022-05-13 |
| 2020-12-31 | $285.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-05-09 | $575.00K derived: sum of 2 quarters · filed 2022-05-09 | $864.00K derived: sum of 3 quarters · filed 2022-05-09 | $1.15M 10-K/A · filed 2022-05-09 |
| 2020-09-30 | $290.00K 10-Q · filed 2021-11-10 | $579.00K derived: sum of 2 quarters · filed 2021-11-10 | $864.00K 10-Q · filed 2021-11-10 | $1.14M derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | $289.00K 10-Q · filed 2021-08-16 | $574.00K 10-Q · filed 2021-08-16 | $854.00K derived: sum of 3 quarters · filed 2021-08-16 | $1.14M derived: sum of 4 quarters · filed 2021-08-16 |
| 2020-03-31 | $285.00K 10-Q · filed 2021-05-13 | $565.00K derived: sum of 2 quarters · filed 2021-05-13 | $852.00K derived: sum of 3 quarters · filed 2021-05-13 | $1.14M derived: sum of 4 quarters · filed 2021-05-13 |
| 2019-12-31 | $280.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-23 | $567.00K derived: sum of 2 quarters · filed 2021-03-23 | $857.00K derived: sum of 3 quarters · filed 2021-03-23 | $1.15M 10-K · filed 2021-03-23 |
| 2019-09-30 | $287.00K 10-Q · filed 2020-11-09 | $577.00K derived: sum of 2 quarters · filed 2020-11-09 | $874.00K 10-Q · filed 2020-11-09 | |
| 2019-06-30 | $290.00K 10-Q · filed 2020-08-10 | $587.00K 10-Q · filed 2020-08-10 | ||
| 2019-03-31 | $297.00K 10-Q · filed 2020-05-11 |